Skip to main content
Top
Published in: Medical Oncology 9/2014

01-09-2014 | Original Paper

Forced vital capacity predicts long-term survival for curative-resected NSCLC

Authors: Xi Guo, Hongxin Cao, Jun Xu, Jianyu Yu, Chunlong Zheng, Long Meng, Jiajun Du

Published in: Medical Oncology | Issue 9/2014

Login to get access

Abstract

We conducted a retrospective study in patients with non-small cell lung cancer (NSCLC) who underwent curative lung resection to seek for better lung function parameters associated with long-term survival after lung resection. From January 2006 to December 2008, 470 patients who underwent lung resection with a postoperative diagnosis of NSCLC were studied. Median survival time was 60 months. Patients with pulmonary function values <80 % of predicted were defined as lung function impairment. Patients with impaired vital capacity, maximal voluntary ventilation, forced vital capacity (FVC), forced expiratory volume in one second (FEV1) or diffusion capacity for carbon monoxide (DLCO) had significant shorter overall survival time (P = 0.024; P = 0.026; P < 0.001; P = 0.027; P = 0.007). In univariate analysis, VC, FVC, FEV1 and DLCO were found to have significant effect on overall survival. In multivariate analysis, FVC (HR, 2.029; 95 % CI 1.126–3.659; P = 0.019) was found to be an independent prognostic predictor of long-term overall survival. For cancer-specific survival, FVC (HR 2.404; 95 % CI 1.300–4.445; P = 0.005) was also found to be an independent prognostic predictor in multivariable analysis. Preoperative FVC, rather than FEV1 or DLCO, is an independent prognostic predictor for long-term survival. FVC is not only an indicator of lung function but also of great value for surgeons to predict survival after lung resection.
Literature
1.
go back to reference Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61(2):69–90 PubMed PMID: 21296855. Epub 2011/02/08. eng.PubMedCrossRef Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61(2):69–90 PubMed PMID: 21296855. Epub 2011/02/08. eng.PubMedCrossRef
2.
go back to reference Sobue T, Suzuki T, Matsuda M, Kuroishi T, Ikeda S, Naruke T. Survival for clinical stage I lung cancer not surgically treated. Comparison between screen-detected and symptom-detected cases. The Japanese Lung Cancer Screening Research Group. Cancer. 1992;69(3):685–92 PubMed PMID: 1730119. Epub 1992/02/01. eng.PubMedCrossRef Sobue T, Suzuki T, Matsuda M, Kuroishi T, Ikeda S, Naruke T. Survival for clinical stage I lung cancer not surgically treated. Comparison between screen-detected and symptom-detected cases. The Japanese Lung Cancer Screening Research Group. Cancer. 1992;69(3):685–92 PubMed PMID: 1730119. Epub 1992/02/01. eng.PubMedCrossRef
3.
go back to reference Boushy SF, Billig DM, North LB, Helgason AH. Clinical course related to preoperative and postoperative pulmonary function in patients with bronchogenic carcinoma. Chest. 1971;59(4):383–91.PubMedCrossRef Boushy SF, Billig DM, North LB, Helgason AH. Clinical course related to preoperative and postoperative pulmonary function in patients with bronchogenic carcinoma. Chest. 1971;59(4):383–91.PubMedCrossRef
4.
go back to reference Wernly JA, DeMeester TR, Kirchner PT, Myerowitz PD, Oxford DE, Golomb HM. Clinical value of quantitative ventilation-perfusion lung scans in the surgical management of bronchogenic carcinoma. J Thorac Cardiovasc Surg. 1980;80(4):535.PubMed Wernly JA, DeMeester TR, Kirchner PT, Myerowitz PD, Oxford DE, Golomb HM. Clinical value of quantitative ventilation-perfusion lung scans in the surgical management of bronchogenic carcinoma. J Thorac Cardiovasc Surg. 1980;80(4):535.PubMed
5.
go back to reference Bousamra M II, Presberg KW, Chammas JH, Tweddell JS, Winton BL, Bielefeld MR, et al. Early and late morbidity in patients undergoing pulmonary resection with low diffusion capacity. Ann Thorac Surg. 1996;62(4):968–75.PubMedCrossRef Bousamra M II, Presberg KW, Chammas JH, Tweddell JS, Winton BL, Bielefeld MR, et al. Early and late morbidity in patients undergoing pulmonary resection with low diffusion capacity. Ann Thorac Surg. 1996;62(4):968–75.PubMedCrossRef
6.
go back to reference Win T, Jackson A, Sharples L, Groves A, Wells F, Ritchie A, et al. Relationship between pulmonary function and lung cancer surgical outcome. Eur Respir J. 2005;25(4):594–9.PubMedCrossRef Win T, Jackson A, Sharples L, Groves A, Wells F, Ritchie A, et al. Relationship between pulmonary function and lung cancer surgical outcome. Eur Respir J. 2005;25(4):594–9.PubMedCrossRef
7.
go back to reference Lee JH, Song EM, Sim YS, Ryu YJ, Chang JH. Forced expiratory volume in one second as a prognostic factor in advanced non-small cell lung cancer. J Thorac Oncol. 2011;6(2):305.PubMedCrossRef Lee JH, Song EM, Sim YS, Ryu YJ, Chang JH. Forced expiratory volume in one second as a prognostic factor in advanced non-small cell lung cancer. J Thorac Oncol. 2011;6(2):305.PubMedCrossRef
8.
go back to reference Ferguson MK, Dignam JJ, Siddique J, Vigneswaran WT, Celauro AD. Diffusing capacity predicts long-term survival after lung resection for cancer. Eur J Cardiothorac Surg. 2012;41(5):e81–6.PubMedCrossRefPubMedCentral Ferguson MK, Dignam JJ, Siddique J, Vigneswaran WT, Celauro AD. Diffusing capacity predicts long-term survival after lung resection for cancer. Eur J Cardiothorac Surg. 2012;41(5):e81–6.PubMedCrossRefPubMedCentral
9.
go back to reference Wang J, Olak J, Ferguson MK. Diffusing capacity predicts operative mortality but not long-term survival after resection for lung cancer. J Thorac Cardiovascu Surg. 1999;117(3):581–7.CrossRef Wang J, Olak J, Ferguson MK. Diffusing capacity predicts operative mortality but not long-term survival after resection for lung cancer. J Thorac Cardiovascu Surg. 1999;117(3):581–7.CrossRef
10.
go back to reference Gray L, Hart CL, Smith GD, Batty GD. What is the predictive value of established risk factors for total and cardiovascular disease mortality when measured before middle age? Pooled analyses of two prospective cohort studies from Scotland. Eur J Cardiovascu Prev Rehabil. 2010;17(1):106–12.CrossRef Gray L, Hart CL, Smith GD, Batty GD. What is the predictive value of established risk factors for total and cardiovascular disease mortality when measured before middle age? Pooled analyses of two prospective cohort studies from Scotland. Eur J Cardiovascu Prev Rehabil. 2010;17(1):106–12.CrossRef
11.
go back to reference Roberts MH, Mapel DW. Limited lung function: impact of reduced peak expiratory flow on health status, health-care utilization, and expected survival in older adults. Am J Epidemiol. 2012;176(2):127–34.PubMedCrossRefPubMedCentral Roberts MH, Mapel DW. Limited lung function: impact of reduced peak expiratory flow on health status, health-care utilization, and expected survival in older adults. Am J Epidemiol. 2012;176(2):127–34.PubMedCrossRefPubMedCentral
12.
go back to reference Liptay MJ, Basu S, Hoaglin MC, Freedman N, Faber LP, Warren WH, et al. Diffusion lung capacity for carbon monoxide (DLCO) is an independent prognostic factor for long-term survival after curative lung resection for cancer. J Surg Oncol. 2009;100(8):703–7.PubMedCrossRef Liptay MJ, Basu S, Hoaglin MC, Freedman N, Faber LP, Warren WH, et al. Diffusion lung capacity for carbon monoxide (DLCO) is an independent prognostic factor for long-term survival after curative lung resection for cancer. J Surg Oncol. 2009;100(8):703–7.PubMedCrossRef
13.
go back to reference Pellegrino R, Viegi G, Brusasco V, Crapo R, Burgos F, Casaburi R, et al. Interpretative strategies for lung function tests. Eur Respir J. 2005;26(5):948–68.PubMedCrossRef Pellegrino R, Viegi G, Brusasco V, Crapo R, Burgos F, Casaburi R, et al. Interpretative strategies for lung function tests. Eur Respir J. 2005;26(5):948–68.PubMedCrossRef
14.
go back to reference Salzman SH. Which pulmonary function tests best differentiate between COPD phenotypes? Respir Care. 2012;57(1):50–60.PubMedCrossRef Salzman SH. Which pulmonary function tests best differentiate between COPD phenotypes? Respir Care. 2012;57(1):50–60.PubMedCrossRef
15.
go back to reference Sekine Y, Behnia M, Fujisawa T. Impact of COPD on pulmonary complications and on long-term survival of patients undergoing surgery for NSCLC. Lung Cancer. 2002;37(1):95–102.PubMedCrossRef Sekine Y, Behnia M, Fujisawa T. Impact of COPD on pulmonary complications and on long-term survival of patients undergoing surgery for NSCLC. Lung Cancer. 2002;37(1):95–102.PubMedCrossRef
16.
go back to reference Korst RJ, Ginsberg RJ, Ailawadi M, Bains MS, Downey RJ, Rusch VW, et al. Lobectomy improves ventilatory function in selected patients with severe COPD. Ann Thorac Surg. 1998;66(3):898–902.PubMedCrossRef Korst RJ, Ginsberg RJ, Ailawadi M, Bains MS, Downey RJ, Rusch VW, et al. Lobectomy improves ventilatory function in selected patients with severe COPD. Ann Thorac Surg. 1998;66(3):898–902.PubMedCrossRef
17.
go back to reference Baldi S, Ruffini E, Harari S, Roviaro GC, Nosotti M, Bellaviti N, et al. Does lobectomy for lung cancer in patients with chronic obstructive pulmonary disease affect lung function? A multicenter national study. J Thorac Cardiovasc Surg. 2005;130(6):1616.PubMedCrossRef Baldi S, Ruffini E, Harari S, Roviaro GC, Nosotti M, Bellaviti N, et al. Does lobectomy for lung cancer in patients with chronic obstructive pulmonary disease affect lung function? A multicenter national study. J Thorac Cardiovasc Surg. 2005;130(6):1616.PubMedCrossRef
18.
go back to reference Vaughan P, Oey I, Nakas A, Martin-Ucar A, Edwards J, Waller D. Is there a role for therapeutic lobectomy for emphysema? Eur J Cardiothorac Surg. 2007;31(3):486–90.PubMedCrossRef Vaughan P, Oey I, Nakas A, Martin-Ucar A, Edwards J, Waller D. Is there a role for therapeutic lobectomy for emphysema? Eur J Cardiothorac Surg. 2007;31(3):486–90.PubMedCrossRef
19.
go back to reference Lee H, Le H, Lee B, Lopez V, Wong N. Forced vital capacity paired with Framingham risk score for prediction of all-cause mortality. Eur Respir J. 2010;36(5):1002–6.PubMedCrossRef Lee H, Le H, Lee B, Lopez V, Wong N. Forced vital capacity paired with Framingham risk score for prediction of all-cause mortality. Eur Respir J. 2010;36(5):1002–6.PubMedCrossRef
20.
go back to reference Burney P, Hooper R. Forced vital capacity, airway obstruction and survival in a general population sample from the USA. Thorax. 2011;66(1):49–54.PubMedCrossRef Burney P, Hooper R. Forced vital capacity, airway obstruction and survival in a general population sample from the USA. Thorax. 2011;66(1):49–54.PubMedCrossRef
21.
go back to reference Anderson H, Vallance P, Bland J, Nohl F, Ebrahim S. Prospective study of mortality associated with chronic lung disease and smoking in Papua New Guinea. Int J Epidemiol. 1988;17(1):56–61.PubMedCrossRef Anderson H, Vallance P, Bland J, Nohl F, Ebrahim S. Prospective study of mortality associated with chronic lung disease and smoking in Papua New Guinea. Int J Epidemiol. 1988;17(1):56–61.PubMedCrossRef
22.
go back to reference Fried LP, Kronmal RA, Newman AB, Bild DE, Mittelmark MB, Polak JF, et al. Risk factors for 5-year mortality in older adults. JAMA. 1998;279(8):585–92.PubMedCrossRef Fried LP, Kronmal RA, Newman AB, Bild DE, Mittelmark MB, Polak JF, et al. Risk factors for 5-year mortality in older adults. JAMA. 1998;279(8):585–92.PubMedCrossRef
23.
go back to reference Lange P, Nyboe J, Appleyard M, Jensen G, Schnohr P. Spirometric findings and mortality in never-smokers. J Clin Epidemiol. 1990;43(9):867–73.PubMedCrossRef Lange P, Nyboe J, Appleyard M, Jensen G, Schnohr P. Spirometric findings and mortality in never-smokers. J Clin Epidemiol. 1990;43(9):867–73.PubMedCrossRef
24.
go back to reference Sorlie PD, Kannel WB, O’Connor G. Mortality associated with respiratory function and symptoms in advanced age: the Framingham study. Am J Respir Crit Care Med. 1989;140(2):379–84. Sorlie PD, Kannel WB, O’Connor G. Mortality associated with respiratory function and symptoms in advanced age: the Framingham study. Am J Respir Crit Care Med. 1989;140(2):379–84.
25.
go back to reference Barker D, Bull A, Osmond C, Simmonds S. Fetal and placental size and risk of hypertension in adult life. Br Med J. 1990;301(6746):259–62.CrossRef Barker D, Bull A, Osmond C, Simmonds S. Fetal and placental size and risk of hypertension in adult life. Br Med J. 1990;301(6746):259–62.CrossRef
26.
go back to reference Barker DJ, Godfrey KM, Fall C, Osmond C, Winter PD, Shaheen SO. Relation of birth weight and childhood respiratory infection to adult lung function and death from chronic obstructive airways disease. BMJ (Clinical research ed). 1991;303(6804):671–5 PubMed PMID: 1912913. Pubmed Central PMCID: PMC1670943. Epub 1991/09/21. eng.CrossRefPubMedCentral Barker DJ, Godfrey KM, Fall C, Osmond C, Winter PD, Shaheen SO. Relation of birth weight and childhood respiratory infection to adult lung function and death from chronic obstructive airways disease. BMJ (Clinical research ed). 1991;303(6804):671–5 PubMed PMID: 1912913. Pubmed Central PMCID: PMC1670943. Epub 1991/09/21. eng.CrossRefPubMedCentral
Metadata
Title
Forced vital capacity predicts long-term survival for curative-resected NSCLC
Authors
Xi Guo
Hongxin Cao
Jun Xu
Jianyu Yu
Chunlong Zheng
Long Meng
Jiajun Du
Publication date
01-09-2014
Publisher
Springer US
Published in
Medical Oncology / Issue 9/2014
Print ISSN: 1357-0560
Electronic ISSN: 1559-131X
DOI
https://doi.org/10.1007/s12032-014-0146-x

Other articles of this Issue 9/2014

Medical Oncology 9/2014 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.